Skip to content
August 15, 2022


Investment information for the new generation

BioVaxys - 14-06- Press Release Thumbnails

VIDEO: BioVaxys Technology (BIOV.C) Receives Positive FDA Response

BioVaxys Technology (BIOV.C) announced today that the US Food and Drug Administration (FDA) has reviewed its pre-IND request for a Type B review of the Company’s Covid-T™ program. Read full article here:

More on

Leave a Reply

Your email address will not be published.